Octo Ventures, based in Oslo, Norway, is an incubator that initiates, invests in, and develops companies together with external co-founders. Based on investment criteria that have proved to deliver superior returns, we have developed a proprietary algorithm that generates high-potential ideas. Our methodology combines best practices within innovation, product development, and business design to accelerate the process from concept development to MVP and commercial launch.

Migraine is an underdiagnosed and undertreated brain disease. 1 in 7 people worldwide is affected by migraine. Nordic Brain Tech develops a treatment that is home-based and self-administered. The invention has gotten worldwide attention from key opinion leaders within migraine. There is a huge market need, and a willingness to pay for the product from both hospitals and migraine patients.

Approximately 50% of Norwegians sell their car to a car dealer. With Nettbils managed marketplace car sellers get offers from 850+ dealers and sell their cars without after-sale risk in less than a workday. - 23% MoM growth since the last investment round in April 2018. - Great customer ratings and case studies from car sellers and car dealerships - First mover advantage in the Norwegian market and currently 1% market share - Easily scalable with NAF and Viking as partners - Own unique custom made tech-platform - With partnership, Nettbil can establish the product in Finland and Denmark

Radiocrafts is a leading RF module design and manufacturing company. Radiocrafts’ standard RF modules provide compact, easy-to-use, low cost, low power and high performance RF solutions for a large number of wireless applications using license-free ISM bands. By using modules OEM manufacturers without RF design knowledge can easily add wireless technology into their design, reducing time-to-market, cost of design, test, and compliance approvals. Radiocrafts also offers custom and application-specific product development, supporting customers from initial project ideas to volume product delivery. Radiocrafts currently provides solutions in the frequency bands 169, 433, 868, 915, and 2450 MHz, supporting radio protocols such as Wireless M-Bus, KNX, ZigBee, 6LoWPAN, SIGFOX, WIZE as well as proprietary solutions such as TinyMesh, RC232, and now our newest product lines, RIIoT and RIIM.

TracSense develops intelligent automotive solutions for the next-generation cars. Primarily the company develops and optical sensor system that can recognize slippery roads. The company's mission is to make autonomous driving possible under all weather conditions. TracSense is an ambitious start-up with its headquarters in Oslo, Norway. Have a look at our website tracsen.se/careers for our current job openings!

eCommerce, B2B, and product development towards tactical, outdoor, and lifestyle products. Office and warehouse in Oslo and eCommerce presence 3 in Norway, Sweden, and Finland. 25 employees and 100MNOK revenue in 2018. We've been growing about 50% yearly over the last three years and aim to continue growing at the same speed. The young data-driven organization with ambitions to become the biggest player within our niche. Come and join us!

Versiro develops software that accelerates the energy transition. Renewable electricity is great for the environment but difficult to plan because its production depends on uncertain weather conditions. Versiro develops an AI copilot that helps renewable producers make smart decisions in real time while considering these uncertainties. This assists the integration of renewable energy and increases its profitability, two key factors to enable the green energy transition. Versiro was founded by researchers at the Norwegian University of Science and Technology (NTNU) and follows the observation that, in electric power systems, the traditional pipelines from research to industry are too outdated to keep up with the fast-paced world of machine learning.

Get your products from the manufacturer to the end customer in the fastest and easiest way possible. Regardless of existing volume or size - NBS provides you with the sales channels, systems, and logistics to reach the whole of Norway. IT-system One system for product registration, sales, statistics, and inventory for your products. Fully integrated with all the services you need. Logistics Efficient logistics from a central warehouse in Vestby of 5,500 m2 specially built for handling beverages. Sales to all channels Sell ​​your products under 4.7% alcohol to private customers through Lokalbrygg.no, over 4.7% alcohol to Vinmonopolet, and everything to HoReCa through horecalevering.no. Marketing and Fairs Increase your visibility through our own fairs for HoReCa, private customers, and Vinmonopolet.

Biozep is discovering and developing first-in-class drug products for the treatment of severe eye diseases which can lead to vision loss and where it is a high unmet medical need. Biozep has discovered novel drug substances based on bioactive lipids which modulate central pathways involved in the pathogenesis of eye diseases. Targets and biomarkers are identified based on a system biology approach combined with in-depth knowledge about bioactive lipids, their endogenous synthesis and mechanisms of action. Biozep has made a prototype drug product based on our lead compound for topical administration and the product will be tested in animal models in 2018. Our goal is to start clinical studies in 2020. Biozep is a company depending on both internal and external resources. Biozep has established its own laboratory in Oslo in order to do synthesis, purification, quality control and chemical development in-house. The biological testing of the drug substances is performed in collaboration with carefully selected contract research organizations both in Europe and the USA. In order to reach the market as fast as possible and to reduce risk, Biozep will seek strategic partnerships early in the drug development phase. Biozep seeks partners with complementary competence and with resources to conduct clinical trials and with market access. We are already in dialogue with potential partners and hope to sign an agreement in 2018-19.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

The company’s purpose is through environmentally friendly technology to operate circular, financially profitable, sustainable activities in material recycling processes of plastic and other organic materials. The company produces and sells end products from chemical processes that convert plastic and organic material into liquid carbon compounds. https://polyfuels.group/polyfuels-group-ab/

LangO is changing the way companies deliver English language training to their employees online. We do this through a blended learning solution; a combination of live virtual lessons (Group Live Lessons and One-to-One) complemented by our on-demand micro-learning activities. Our responsive web app brings in the best-qualified teachers from around the world, custom-made LangO lesson content based on client's needs, and a scalable tech stack enabling employees to learn effectively on any device, at any time.

BRIK as is a company specialising in new web technology, pedagogy and professional dissemination of knowledge. The team has extensive experience in the dissemination of knowledge with new web technologies and video. Our investors and partners are Innovation Norway, the Norwegian Research Council and several customer partners. The budget for the initial development phase (2013 - ) has been 12 MNOK. Now we are looking for partners for the next stage, where we will commercialize and increase sales.

Vi forenkler hverdagen Rubic ble etablert i April 2014 med mål om å forenkle hverdagen for lag og foreninger i Norge. Vår ambisjon er å bli markedsleder i Norge for medlemsbaserte organisasjoner. Vi leverer ekspertise og systemer innenfor privat-, offentlig- og frivillig sektor. Drift smartere, mer tid Vi hjelper din forening med å drive profesjonelt og yte bedre service til deres medlemmer.

Evoltec (Evolution Technologies) is a Norwegian-based technological integrated service Company, established in January 2015. We are an evolving technological services and products provider with a focus on the marine and energy industry, In particular within the oil and gas sector. We realize and value our customer`s business needs and build cost-effective yet time-bound solutions to meet specific requirements. Our network of qualified personnel and product suppliers is capable of delivering services and products all over the world.